Related Experiment Videos
How to participate in a multiple sclerosis clinical trial
1Laboratory of Diagnostic Radiology Research, Clinical Center, National Institutes of Health, 10 Center Drive MSC 1074, Bethesda, MD 20892, USA. jafrank@helix.nih.gov
Neuroimaging Clinics of North America
|May 22, 2001
Summary
Magnetic Resonance (MR) imaging is crucial for understanding multiple sclerosis (MS) progression and is essential for clinical trials evaluating new MS treatments. This overview guides researchers on utilizing MR imaging in MS studies.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease affecting the brain and spinal cord.
- Understanding the natural history and pathological processes of MS is critical for effective treatment.
- Magnetic Resonance (MR) imaging has become indispensable in MS research and patient care.
Purpose of the Study:
- To provide an overview of MR imaging's role in multiple sclerosis clinical research.
- To guide researchers on incorporating MR imaging techniques into MS clinical trials.
- To discuss the utility of MR imaging as a surrogate outcome measure in MS treatment studies.
Main Methods:
- Review of conventional and advanced MR imaging techniques applicable to MS.
- Analysis of MR imaging's current role in the design and execution of MS clinical trials.
- Discussion on the application of MR imaging for assessing treatment efficacy in MS.
Main Results:
- MR imaging significantly enhances the understanding of MS natural history and pathology.
- MR imaging is a standard component in all contemporary MS clinical trials.
- The application of MR imaging as a surrogate outcome measure is actively being explored.
Conclusions:
- MR imaging is a vital tool for MS research, offering insights into disease mechanisms.
- Effective utilization of MR imaging techniques is essential for successful MS clinical trial design.
- Continued research into MR imaging applications will further advance MS therapeutic development.